Potentiation of penile tumescence by T-1032, a new potent and specific phosphodiesterase type V inhibitor, in dogs

Journal of Pharmacology and Experimental Therapeutics

Volumn 294, Issue 3, 2000, Pages 870-875

  Noto, T ^a   Inoue, H ^a   Ikeo, T ^a   Kikkawa, K ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL 2 (4 AMINOPHENYL) 1,2 DIHYDRO 1 OXO 7 (2 PYRIDINYLMETHOXY) 4 (3,4,5 TRIMETHOXYPHENYL) 3 ISOQUINOLINE CARBOXYLATE SULFATE; N(G) NITROARGININE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE V; SILDENAFIL; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DOG; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; ENZYME INHIBITOR COMPLEX; ERECTILE DYSFUNCTION; MALE; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL;

ANIMALS; CYCLIC AMP; CYCLIC GMP; DOGS; ELECTRIC STIMULATION; ENZYME INHIBITORS; ISOQUINOLINES; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROARGININE; NITROPRUSSIDE; PENILE ERECTION; PENIS; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PYRIDINES; STEREOISOMERISM; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0033838119     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Pharmacology of lower urinary tract smooth muscles and penile erectile tissues
2. Physiology of penile erection
3. Pelvic nerve stimulation-induced pressor responses in corpus cavernosum of anesthetized dogs
4. Endothelium-derived nitric oxide and cyclooxygenase products modulate corpus cavernosum smooth muscle tone
5. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes
6. Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction
7. Sildenafil, a novel effective oral therapy for male erectile dysfunction
8. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding
9. Nitric oxide: A physiologic mediator of penile erection
10. Nitric oxide is a potent relaxant of human and rabbit corpus cavernosum
11. Biosynthesis of nitric oxide and citrulline from L-arginine by constitutive nitric oxide synthase present in rabbit corpus cavernosum
12. Effect of the selective phosphodiesterase type 5 inhibitor sildenafil on erectile dysfunction in the anesthetized dog
13. Sildenafil, a type-5 CGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro
14. cGMP mediates corpus cavernosum smooth muscle relaxation with altered cross-bridge function
15. Sodium nitroprus-side and neurostimulation cause increased levels of cyclic guanosine monophosphate and not cyclic adenosine monophosphate during canine penile erection
16. Nitric oxide release in penile corpora cavernosa in a rat model of erection. J Physiol (Lond)
17. Inhibition of nerve stimulation-induced vasodilatation in corpora cavernosa of the pithed rat by blockade of nitric oxide synthase
18. Oral sildenafil in the treatment of erectile dysfunction
19. Pituitary adenylate cyclase-activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum
20. Distribution and function of nitric oxide-containing nerves in canine corpus cavernosum and spongiosum
21. Non-synergistic relaxant effects of vasoactive intestinal polypeptide and SIN-1 in human isolated cavernous artery and corpus cavernosum
22. Actions of 3-morpholinosydnonimin (SIN-1) on rabbit isolated penile erectile tissue
23. Characterization of inhibitory neurotransmission in the isolated corpus cavernosum from rabbit and man
24. Effects of the nitric oxide synthase inhibitor N(G)-nitro-L-arginine on the erectile response to cavernous nerve stimulation in the rabbit
25. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle
26. A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle
27. Characterization and effects of T-1032, a novel potent inhibitor of cGMP-binding cGMP-specific phosphodiesterase (PDE5)
28. Cyclic guanosine monophosphate mediates penile erection in the rat
29. Levels of nitric oxide metabolites do not increase during penile erection
30. Effects of endothelial impairment by saponin on the responses to vasodilators and nitrergic nerve stimulation in isolated canine corpus cavernosum
31. The effect of inhibitors of nitric oxide biosynthesis and cyclic GMP formation on nerve-evoked relaxation of human cavernosal smooth muscle
32. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission
33. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo
34. Smooth muscle tone regulation in rabbit cavernosal and spongiosal tissue by cyclic AMP- and cyclic GMP-dependent mechanisms
35. The effect of the specific phosphodiesterase (PDE) inhibitors on human and rabbit cavernous tissue in vitro and in vivo
36. Nitric oxide and cGMP: Mediators of pelvic nerve-stimulated erection in dogs
37. The role of cyclic adenosine monophosphate, cyclic guanosine monophosphate, endothelium and nonadrenergic, noncholinergic neurotransmission in canine penile erection
38. Nitric oxide mediates penile erection in cats
39. Two pathways of nitric oxide production through glutamate receptors in the rat cerebellum in vivo